利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

5 条记录 (耗时 0.035 秒)

    Magnet pole for magnetic levitation vehicles, and method for the production thereof
    2.
    发明申请
    Magnet pole for magnetic levitation vehicles, and method for the production thereof 有权
    用于磁悬浮车辆的磁极及其制造方法

    公开(公告)号：US20120126921A1

    公开(公告)日：2012-05-24

    申请号：US13387797

    申请日：2010-07-29

    申请人： Peter Bugiel ,  Andreas Diekmann ,  Joachim Kraemer ,  Daniel Tschada ,  Qinghua Zheng

    发明人： Peter Bugiel ,  Andreas Diekmann ,  Joachim Kraemer ,  Daniel Tschada ,  Qinghua Zheng

    IPC分类号： H01F7/00 ,  H01F41/00

    CPC分类号： B60L13/04 ,  H01F1/14 ,  H02K41/02

    摘要： The invention relates to a magnet pole for magnetic levitation vehicles, containing an iron core (1), a coil (6) applied thereon, a rear (4) of a magnet lying against a lower contact surface (3) of the iron core (1), and a protective layer (9) that encases the coil (6) and an upper pole surface (2) of the iron core (1). The protective layer (9) has a section (15) made of an elastic material in a lower region of the iron core (1), said section bordering the circumferential surface (5) of the iron core.

    摘要翻译： 本发明涉及一种用于磁悬浮车辆的磁极，其包含铁芯（1），施加在其上的线圈（6），位于铁芯的下接触表面（3）上的磁体的后部（4） 1）和包围铁心（1）的线圈（6）和上极面（2）的保护层（9）。 保护层（9）具有在铁芯（1）的下部区域中由弹性材料制成的部分（15），所述部分与铁芯的圆周表面（5）相邻。

    PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT
    3.
    发明申请
    PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT 有权
    苯基取代的马来酰亚胺作为通过抑制MPT阻断变性组织损伤的药物

    公开(公告)号：US20100099736A1

    公开(公告)日：2010-04-22

    申请号：US12444407

    申请日：2007-09-21

    申请人： PierGiuseppe Pellicci ,  Marco Giorgio ,  Saverio Minucci ,  Paolo Bernardi ,  Gilles Pain ,  Stephen Martin Courtney ,  Christopher John Yarnold ,  Joachim Kraemer

    发明人： PierGiuseppe Pellicci ,  Marco Giorgio ,  Saverio Minucci ,  Paolo Bernardi ,  Gilles Pain ,  Stephen Martin Courtney ,  Christopher John Yarnold ,  Joachim Kraemer

    IPC分类号： A61K31/4015 ,  A61P25/00 ,  A61P3/10

    CPC分类号： A61K31/4025 ,  C07D207/444 ,  C07D207/448 ,  C07D207/452 ,  Y10S514/866

    摘要： The invention discloses the use of a compound of formula (I), wherein R1, R2, R3, and R4 each independently represents: hydrogen; halo; hydroxy; (C1-C6) alkyl optionally substituted by hydroxy or (C1-C4) alkoxy; (C1-C6) haloalkyl; (C1-C6) alkoxy; and (C1-C6) haloalkoxy; for the preparation of a medicament for the prevention and/or treatment of diseases resulting from opening of the MPTP which are characterized by degenerative tissue damages, in particular, diabetes and diabetic complications, neurological diseases and stroke, heart infarction, inherited dystrophies and hepatitis, more particularly, diabetic vascular diseases, such as diabetic retinopathy, and neurodegenerative disorders, such as multiple sclerosis. Further objects are a group of selected individual compounds of formula (I) for use as medicaments and a further group of selected individual compounds of formula (I) as novel compounds.

    摘要翻译： 本发明公开了式（I）化合物的用途，其中R 1，R 2，R 3和R 4各自独立地表示：氢; 光环; 羟基; 任选被羟基或（C 1 -C 4）烷氧基取代的（C 1 -C 6）烷基; （C 1 -C 6）卤代烷基; （C 1 -C 6）烷氧基; 和（C 1 -C 6）卤代烷氧基; 用于制备用于预防和/或治疗MPTP开放引起的疾病的药物，其特征在于退行性组织损伤，特别是糖尿病和糖尿病并发症，神经系统疾病和中风，心脏梗死，遗传性营养不良和肝炎， 更具体地，糖尿病性血管疾病，例如糖尿病性视网膜病变，和神经变性疾病如多发性硬化。 另外的目的是用作药物的一组选定的式（I）化合物和另一组选择的式（I）化合物作为新化合物。

    Magnet pole for magnetic levitation vehicles, and method for the production thereof
    4.
    发明授权
    Magnet pole for magnetic levitation vehicles, and method for the production thereof 有权
    用于磁悬浮车辆的磁极及其制造方法

    公开(公告)号：US08477004B2

    公开(公告)日：2013-07-02

    申请号：US13387797

    申请日：2010-07-29

    申请人： Peter Bugiel ,  Andreas Diekmann ,  Joachim Kraemer ,  Daniel Tschada ,  Qinghua Zheng

    发明人： Peter Bugiel ,  Andreas Diekmann ,  Joachim Kraemer ,  Daniel Tschada ,  Qinghua Zheng

    IPC分类号： H01F7/00 ,  H01F41/00

    CPC分类号： B60L13/04 ,  H01F1/14 ,  H02K41/02

    摘要： A magnet pole for magnetic levitation vehicles includes an iron core (1) having an upper pole surface (2), a lower contact surface (3) for a magnet rear side (4) and a circumferential surface (5) disposed between the pole surface (2) and the contact surface (3). A coil (6) is applied onto the circumferential surface (5) of the iron core (1). An intermediate layer is made of an electrically insulating material, which is disposed between the circumferential surface (5) and the coil (6). A protective layer (9) encapsulates the coil (6). At least the pole surface (2) of the iron core (1) is made of a hard material and abuts the circumferential surface (5) in a lower region of the iron core (1). The protective layer (9) contains a section (15) made of an elastic material in a region adjacent to the circumferential surface (5).

    摘要翻译： 用于磁悬浮车辆的磁极杆包括具有上磁极表面（2）的铁芯（1），用于磁体后侧（4）的下接触表面（3）和设置在磁极表面之间的圆周表面（5） （2）和接触表面（3）。 将一个线圈（6）施加到铁芯（1）的圆周表面（5）上。 中间层由设置在圆周表面（5）和线圈（6）之间的电绝缘材料制成。 保护层（9）封装线圈（6）。 至少铁芯（1）的极面（2）由硬质材料制成，并与铁芯（1）的下部区域邻接圆周表面（5）。 保护层（9）在与周面（5）相邻的区域中包含由弹性材料制成的部分（15）。

    Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPT
    5.
    发明授权
    Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPT 有权
    苯基取代的马来酰亚胺作为通过抑制MPT阻断退行性组织损伤的药物

    公开(公告)号：US07915304B2

    公开(公告)日：2011-03-29

    申请号：US12444407

    申请日：2007-09-21

    申请人： PierGiuseppe Pellicci ,  Marco Giorgio ,  Saverio Minucci ,  Paolo Bernardi ,  Gilles Pain ,  Stephen Martin Courtney ,  Christopher John Yarnold ,  Joachim Kraemer

    发明人： PierGiuseppe Pellicci ,  Marco Giorgio ,  Saverio Minucci ,  Paolo Bernardi ,  Gilles Pain ,  Stephen Martin Courtney ,  Christopher John Yarnold ,  Joachim Kraemer

    IPC分类号： A01N43/36 ,  A61K31/40

    CPC分类号： A61K31/4025 ,  C07D207/444 ,  C07D207/448 ,  C07D207/452 ,  Y10S514/866

    摘要： The invention discloses the use of a compound of formula (I), wherein R1, R2, R3, and R4 each independently represents: hydrogen; halo; hydroxy; (C1-C6) alkyl optionally substituted by hydroxy or (C1-C4) alkoxy; (C1-C6) haloalkyl; (C1-C6) alkoxy; and (C1-C6) haloalkoxy; for the preparation of a medicament for the prevention and/or treatment of diseases resulting from opening of the MPTP which are characterized by degenerative tissue damages, in particular, diabetes and diabetic complications, neurological diseases and stroke, heart infarction, inherited dystrophies and hepatitis, more particularly, diabetic vascular diseases, such as diabetic retinopathy, and neurodegenerative disorders, such as multiple sclerosis. Further objects are a group of selected individual compounds of formula (I) for use as medicaments and a further group of selected individual compounds of formula (I) as novel compounds.

    摘要翻译： 本发明公开了式（I）化合物的用途，其中R 1，R 2，R 3和R 4各自独立地表示：氢; 光环; 羟基; 任选被羟基或（C 1 -C 4）烷氧基取代的（C 1 -C 6）烷基; （C 1 -C 6）卤代烷基; （C 1 -C 6）烷氧基; 和（C 1 -C 6）卤代烷氧基; 用于制备用于预防和/或治疗MPTP开放引起的疾病的药物，其特征在于退行性组织损伤，特别是糖尿病和糖尿病并发症，神经系统疾病和中风，心脏梗死，遗传性营养不良和肝炎， 更具体地，糖尿病性血管疾病，例如糖尿病性视网膜病变，和神经变性疾病如多发性硬化。 另外的目的是用作药物的一组选定的式（I）化合物和另一组选择的式（I）化合物作为新化合物。